SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000904454-23-000572
Filing Date
2023-10-19
Accepted
2023-10-19 15:33:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 OCT 2023 FILING, IKENA ONC AS ISSUER FOR GILEAD SCIENCES, THE REPORTING PERSON s13g_101123-gilead.htm SC 13G 48171
  Complete submission text file 0000904454-23-000572.txt   49780
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Subject) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92449 | Film No.: 231334629
SIC: 2836 Biological Products, (No Diagnostic Substances)